All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer. [electronic resource]
Producer: 20130613Description: 913-9 p. digitalISSN:- 1432-0843
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- chemistry
- Capecitabine
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Middle Aged
- Neoplasm Metastasis
- Receptor, ErbB-2 -- analysis
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.